Nipah Virus: 91% Fatality Rate, Spreads from Bats, Early Detection Key

The Nipah virus, which circulates freely in bats, can jump to humans causing severe brain infection or pneumonia with an extremely high fatality rate. Initial symptoms like fever and headache can progress to seizures, confusion, or coma, often leading to missed diagnoses. The virus can spread from person to person through close contact and exposure to body fluids, putting healthcare workers and caregivers at risk. With no effective antiviral or vaccine available, early detection, patient isolation, and rigorous contact tracing are the primary tools to prevent outbreaks.

Key Points: Nipah Virus: High Death Rate, Spread, and Early Detection

  • High fatality rate of 73-91%
  • Spreads from bats to humans via contact
  • Can transmit between people via body fluids
  • No specific treatment or vaccine exists
  • Early diagnosis and contact tracing are critical
4 min read

"Nipah Virus spreads from bats to humans, early detection crucial", Dr Rajeev Jayadevan

Dr. Rajeev Jayadevan warns Nipah virus from bats has 73-91% fatality rate. Learn symptoms and why early diagnosis and contact tracing are crucial.

"The death rate from Nipah can range from 73 per cent to 91 per cent. - Dr Rajeev Jayadevan"

Kochi, January 26

Dr Rajeev Jayadevan, Ex-President of IMA Cochin and Convener of the Research Cell, Kerala, on Monday warned that the Nipah virus spreads from bats to humans and can cause severe illness with a high death rate, stressing the importance of early detection to prevent further spread.

In a video message, Jayadevan said, "Nipah virus circulates freely among bats, and they don't seem to die from it. But when human beings come into contact with bats, either directly or indirectly, the virus may accidentally jump into man, the virus can cause a severe form of brain infection or pneumonia, both of which carry a very high fatality rate. The death rate from Nipah can range from 73 per cent to 91 per cent. The initial symptoms are fever, body ache, headache, but in people who develop brain infection after that, they may get seizures or epilepsy, confusion, paralysis or coma. The symptoms are similar to those of other types of brain infection caused by other viruses. Sometimes a diagnosis of Nipah can be missed because it is not specifically tested for. The problem with Nipah is that it can also spread from patient to patient. So it's extremely important to identify the first patient who develops the infection."

He said early diagnosis, isolation, and contact tracing are crucial to prevent the spread of the Nipah virus, as it can pass from person to person through close contact and body fluids, including to healthcare workers and caregivers.

"Unfortunately, in many cases, the first patient is either very ill or may have died by the time the diagnosis is ascertained, which means this person may have passed on this virus to other people, and these other people if they develop symptoms like cough, vomiting or seizures and get admitted to a hospital, sometimes people who treat this person like nurses or doctors or other hospital staff may also get infected. Other caregivers at the patient's home who tend to the patient's body fluids can also get infected; it is extremely important, one, to make an early diagnosis. Two, to isolate a patient, and three, to treat the patient with standard precautions such as masks and gloves. Even more important is tracking the contacts of these patients, because the Nipah virus can jump from person to person and cause a potentially fatal infection, which is why contact tracing is of great value in limiting the size of the outbreak. Fortunately, unlike covid, Nipah does not have the ability to spread fast from person to person. Typically, it occurs through very close bodily contact or by handling the person's body fluids, or exposure to the person's body fluids," he said.

Jayadevan said there is no specific treatment or vaccine for the Nipah virus, making supportive care and contact tracing critical to prevent its spread, while noting that Nipah is a zoonotic disease that can jump from animals to humans.

"Unfortunately, the Nipah virus has no effective antiviral treatment or vaccine that is available. Therefore, the treatment measures are only supportive and are extremely important for limiting the size of the outbreak and preventing the virus from spreading far and wide to many people. This is why contact tracing is so valuable. Nipah is one of several viruses that may accidentally jump from animals to humans, and this category of disease is called a zoonosis. A common zoonosis that we are all familiar with is rabies. It commonly circulates in wild foxes that may come into contact with dogs while searching for food in the border areas of the jungle. These viruses circulate among stray dogs and can also jump onto pet cats and dogs, especially if they are not vaccinated," he said.

- ANI

Share this article:

Reader Comments

R
Rohit P
The fatality rate is terrifying! 73-91% is no joke. Dr. Jayadevan is right, we need to test for it specifically. After COVID, our labs should be better equipped for this. Hope the government is allocating funds for rapid test kits in vulnerable districts.
A
Aman W
People need to be educated not to consume fruits that are partially eaten or found on the ground, especially in regions like Kerala and parts of the Northeast. Bats are a natural reservoir. Public awareness is our first line of defense. 🙏
S
Sarah B
As someone who lived in Kozhikode during the 2018 outbreak, this brings back scary memories. The contact tracing then was heroic. We must support our healthcare workers with proper PPE. They are the real frontline warriors against such deadly viruses.
V
Vikram M
While the doctor's points are valid, I feel the article could have emphasized more on what common citizens should *practically* do. "Avoid contact with bats" is vague. Clearer guidelines on handling livestock and securing food from bat contamination are needed.
K
Karthik V
No vaccine and no specific treatment... this is a wake-up call for our research institutions. We need a dedicated 'Mission Nipah' for vaccine development, just like we had for COVID. Zoonotic diseases are going to be a recurring challenge.
N

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50